Go to
JCI Insight
Citations to this article
Ying Yang, … , Kai Wang, Andreas Lundqvist
Published July 16, 2020
Citation Information: J Clin Invest. 2020;130(10):5508-5522. https://doi.org/10.1172/JCI137585.
Citation Information: J Clin Invest. 2020;130(10):5508-5522. https://doi.org/10.1172/JCI137585.
Abstract
To improve the clinical outcome of adoptive NK cell therapy in patients with solid tumors, NK cells need to persist within the tumor microenvironment (TME) in which the abundance of ROS could dampen antitumor immune responses. In the present study, we demonstrated that IL-15–primed NK cells acquired resistance against oxidative stress through the thioredoxin system activated by mTOR. Mechanistically, the activation of thioredoxin showed dependence on localization of thioredoxin-interacting protein. We show that NK cells residing in the tumor core expressed higher thiol densities that could aid in protecting other lymphocytes against ROS within the TME. Furthermore, the prognostic value of IL15 and the NK cell gene signature in tumors may be influenced by tobacco smoking history in patients with non–small-cell lung cancer (NSCLC). Collectively, the levels of reducing antioxidants in NK cells may not only predict better tumor penetrance but potentially even the immune therapy response.
Authors
Ying Yang, Shi Yong Neo, Ziqing Chen, Weiyingqi Cui, Yi Chen, Min Guo, Yongfang Wang, Haiyan Xu, Annina Kurzay, Evren Alici, Lars Holmgren, Felix Haglund, Kai Wang, Andreas Lundqvist
Citation information
Citations to this article (53)
| Title and authors | Publication | Year |
|---|---|---|
|
Adaptation of Natural Killer Cells to Hypoxia: A Review of the Transcriptional, Translational, and Metabolic Processes
Chang TD, Chen YJ, Luo JL, Zhang C, Chen SY, Lin ZQ, Zhang PD, Shen YX, Tang TX, Li H, Dong LM, Tang ZH, Chen D, Wang YM |
ImmunoTargets and Therapy | 2025 |
|
Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies
Chmelyuk N, Kordyukova M, Sorokina M, Sinyavskiy S, Meshcheryakova V, Belousov V, Abakumova T |
International Journal of Molecular Sciences | 2025 |
|
A prognostic model based on autophagy-and senescence-related genes for gastric cancer: implications for immunotherapy and personalized treatment
Chen S, Han X, Lu Y, Wang S, Fang Y, Leng C, Sun X, Li X, Qiu W, Qi W |
Frontiers in Oncology | 2025 |
|
IL-15 functionalized biomimetic hybrid mRNA vaccine for enhanced NSCLC immunotherapy via synergistic activation of T cells and NK cells
Guo J, Peng L, Ma P, Mai Y, Gao T, Yu N, Zuo W, Yang J |
Materials Today Bio | 2025 |
|
Hypoxic Natural Killer Cells-Derived HIF-1α-Containing Exosomes Inhibit Cellular Senescence and Apoptosis in Neurocytes to Ameliorate Alzheimer's Disease by Eliminating Oxidative Damages.
Zhou Y, Rong Y |
Molecular neurobiology | 2025 |
|
Research progress on mitochondria regulating tumor immunity.
Li J, Xu P, Chen S |
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences | 2024 |
|
Roles of reactive oxygen species in inflammation and cancer
Yu Y, Liu S, Yang L, Song P, Liu Z, Liu X, Yan X, Dong Q |
2024 | |
|
Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics
Dagah OM, Silaa BB, Zhu M, Pan Q, Qi L, Liu X, Liu Y, Peng W, Ullah Z, Yudas AF, Muhammad A, Zhang X, Lu J |
Antioxidants | 2024 |
|
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
Pesini C, Artal L, Paúl Bernal J, Sánchez Martinez D, Pardo J, Ramírez-Labrada A |
OncoImmunology | 2024 |
|
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.
Deng J, Pan T, Wang D, Hong Y, Liu Z, Zhou X, An Z, Li L, Alfano G, Li G, Dolcetti L, Evans R, Vicencio JM, Vlckova P, Chen Y, Monypenny J, Gomes CAC, Weitsman G, Ng K, McCarthy C, Yang X, Hu Z, Porter JC, Tape CJ, Yin M, Wei F, Rodriguez-Justo M, Zhang J, Tejpar S, Beatson R, Ng T |
EMBO molecular medicine | 2024 |
|
The Association between NADPH Oxidase 2 (NOX2) and Drug Resistance in Cancer.
Dong S, Chen C, Di C, Wang S, Dong Q, Lin W, Liu D |
Current cancer drug targets | 2024 |
|
Reactive oxygen species: Janus-faced molecules in the era of modern cancer therapy
O\u2019Reilly A, Zhao W, Wickström S, Arnér ES, Kiessling R |
Journal for Immunotherapy of Cancer | 2024 |
|
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer.
Viel S, Vivier E, Walzer T, Marçais A |
Nature reviews. Drug discovery | 2024 |
|
Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
Stravokefalou V, Stellas D, Karaliota S, Nagy BA, Valentin A, Bergamaschi C, Dimas K, Pavlakis GN |
Frontiers in immunology | 2023 |
|
CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppression
Chen Z, Tong L, Neo SY, Li S, Gao J, Schlisio S, Lundqvist A |
OncoImmunology | 2023 |
|
Unravelling the role of obesity and lipids during tumor progression
Zhao J, Lee K, Toh HC, Lam KP, Neo SY |
Frontiers in pharmacology | 2023 |
|
Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
Andolfo I, Monaco V, Cozzolino F, Rosato BE, Marra R, Cerbone V, Pinto VM, Forni GL, Unal S, Iolascon A, Monti M, Russo R |
Blood Advances | 2023 |
|
Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.
Zheng Z, Su J, Bao X, Wang H, Bian C, Zhao Q, Jiang X |
Frontiers in immunology | 2023 |
|
NK cells direct the perspective approaches to cancer immunotherapy.
Jalil AT, Abdulhadi MA, Al-Marzook FA, Hizam MM, Abdulameer SJ, Al-Azzawi AKJ, Zabibah RS, Fadhil AA |
Medical Oncology | 2023 |
|
Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors
Lin X, Dong Y, Gu Y, Wei F, Peng J, Su Y, Wang Y, Yang C, Neira SV, Kapoor A, Tang D |
Cancers | 2023 |
|
Single-Cell RNA Sequencing of Coronary Perivascular Adipose Tissue From End-Stage Heart Failure Patients Identifies SPP1+ Macrophage Subpopulation as a Target for Alleviating Fibrosis
Fu M, Shu S, Peng Z, Liu X, Chen X, Zeng Z, Yang Y, Cui H, Zhao R, Wang X, Du L, Wu M, Feng W, Song J |
Arteriosclerosis, thrombosis, and vascular biology | 2023 |
|
A Th17 cell-intrinsic glutathione/mitochondrial-IL-22 axis protects against intestinal inflammation
Bonetti L, Horkova V, Longworth J, Guerra L, Kurniawan H, Franchina DG, Soriano-Baguet L, Grusdat M, Spath S, Koncina E, Ewen A, Binsfeld C, Verschueren C, Gérardy JJ, Kobayashi T, Dostert C, Farinelle S, Härm J, Chen Y, Harris IS, Lang PA, Vasiliou V, Waisman A, Letellier E, Becher B, Mittelbronn M, Brenner D |
2023 | |
|
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.
Deng J, Pan T, Liu Z, McCarthy C, Vicencio JM, Cao L, Alfano G, Suwaidan AA, Yin M, Beatson R, Ng T |
British Journal of Cancer | 2023 |
|
Acute Exercise Increases NK Cell Mitochondrial Respiration and Cytotoxicity against Triple-Negative Breast Cancer Cells under Hypoxic Conditions
CHO E, STAMPLEY J, WALL R, MATTHEWS R, ZUNICA E, BROWN JC, JOHANNSEN NM, IRVING BA, SPIELMANN G |
Medicine and science in sports and exercise | 2023 |
|
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
N Maskalenko, D Zhigarev, K Campbell |
Nature Reviews Drug Discovery | 2022 |
|
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress.
Renken S, Nakajima T, Magalhaes I, Mattsson J, Lundqvist A, Arnér ESJ, Kiessling R, Wickström SL |
Journal for ImmunoTherapy of Cancer | 2022 |
|
Emerging Evidence of the Significance of Thioredoxin-1 in Hematopoietic Stem Cell Aging
Jabbar S, Mathews P, Kang Y |
Antioxidants | 2022 |
|
A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.
Tay AHM, Prieto-Díaz R, Neo S, Tong L, Chen X, Carannante V, Önfelt B, Hartman J, Haglund F, Majellaro M, Azuaje J, Garcia-Mera X, Brea JM, Loza MI, Jespers W, Gutierrez-de-Teran H, Sotelo E, Lundqvist A |
Journal for ImmunoTherapy of Cancer | 2022 |
|
Redox regulation of the immune response.
Morris G, Gevezova M, Sarafian V, Maes M |
Cellular & molecular immunology | 2022 |
|
The antitumor activity of hPRDX5 against pancreatic cancer and the possible mechanisms.
Cui L, Jin Y, Zou S, Xun J, Yu X, Zhang Q, Yang Z |
2022 | |
|
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Kuo CL, Ponneri Babuharisankar A, Lin YC, Lien HW, Lo YK, Chou HY, Tangeda V, Cheng LC, Cheng AN, Lee AY |
Journal of biomedical science | 2022 |
|
Mitophagy and reactive oxygen species interplay in Parkinson’s disease
Xiao B, Kuruvilla J, Tan EK |
npj Parkinson's Disease | 2022 |
|
NK cells and solid tumors: therapeutic potential and persisting obstacles.
Tong L, Jiménez-Cortegana C, Tay AHM, Wickström S, Galluzzi L, Lundqvist A |
Molecular Cancer | 2022 |
|
The prospect of genetically engineering natural killer cells for cancer immunotherapy.
Poon AYC, Sugimura R |
Biology Open | 2022 |
|
Expression of TRX1 optimizes the antitumor functions of human CAR T cells and confers resistance to a pro-oxidative tumor microenvironment
Balta E, Janzen N, Kirchgessner H, Toufaki V, Orlik C, Liang J, Lairikyengbam D, Abken H, Niesler B, Müller-Decker K, Ruppert T, Samstag Y |
Frontiers in immunology | 2022 |
|
Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy
Du Y, Zhang Z, Yang Y, Liu T, Chen T, Li X |
Nanophotonics | 2022 |
|
Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer
B Yang, Q Chen, X Zhan |
Oxidative Medicine & Cellular Longevity | 2021 |
|
Immune cell - produced ROS and their impact on tumor growth and metastasis
KB Kennel, FR Greten |
Redox Biology | 2021 |
|
Mitochondria Homeostasis and Oxidant/Antioxidant Balance in Skeletal Muscle—Do Myokines Play a Role?
BP Pang, WS Chan, CB Chan |
Antioxidants | 2021 |
|
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
NS Aboelella, C Brandle, T Kim, ZC Ding, G Zhou |
Cancers | 2021 |
|
Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment
P Ahluwalia, M Ahluwalia, AK Mondal, NS Sahajpal, V Kota, MV Rojiani, R Kolhe |
Cancers | 2021 |
|
Gastric cancer mesenchymal stem cells inhibit natural killer cell function by up-regulating FBP1
F Han, S Guo, C Huang, L Cui, Y Zhao, J Ma, M Zhu, Z Chen, M Wang, B Shen, W Zhu |
CENT EUR J IMMUNOL | 2021 |
|
A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
T Fan, Z Lu, Y Liu, L Wang, H Tian, Y Zheng, B Zheng, L Xue, F Tan, Q Xue, S Gao, C Li, J He |
Frontiers in immunology | 2021 |
|
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
P Wu, W Gao, M Su, EC Nice, W Zhang, J Lin, N Xie |
Frontiers in Cell and Developmental Biology | 2021 |
|
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
C Griñan-Lison, JL Blaya-Cánovas, A López-Tejada, M Ávalos-Moreno, A Navarro-Ocón, FE Cara, A González-González, JA Lorente, JA Marchal, S Granados-Principal |
Antioxidants | 2021 |
|
CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma
Y Su, P Tsagkozis, A Papakonstantinou, NP Tobin, O Gultekin, A Malmerfelt, K Ingelshed, SY Neo, J Lundquist, W Chaabane, MH Nisancioglu, LW Leiss, A Östman, J Bergh, S Sedimbi, K Lehti, A Lundqvist, CL Stragliotto, F Haglund, M Ehnman |
Cancers | 2021 |
|
Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments
J Zhou, M Zhang, Y Zhang, , L Liu, R Yao |
Frontiers in Genetics | 2021 |
|
Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and function
P Trikha, J Moseman, A Thakkar, A Campbell, E Elmas, J Foltz, N Chakravarti, J Fitch, E Mardis, D Lee |
Blood Advances | 2021 |
|
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress
Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagala J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M |
Cancer immunology research | 2021 |
|
NK cells in the tumor microenvironment and thioredoxin activity
Theresa L Whiteside |
Journal of Clinical Investigation | 2020 |
|
Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
Y Yang, A Lundqvist |
Cancers | 2020 |
|
Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19
R Jia, X Wang, P Liu, X Liang, Y Ge, H Tian, H Chang, H Zhou, M Zeng, J Xu |
Virologica Sinica | 2020 |
|
Physical Plasma-Treated Skin Cancer Cells Amplify Tumor Cytotoxicity of Human Natural Killer (NK) Cells
R Clemen, P Heirman, A Lin, A Bogaerts, S Bekeschus |
Cancers | 2020 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)